Literature DB >> 30378040

Clinical Management and Surgical Decision-Making of IPMN of the Pancreas.

Masao Tanaka1.   

Abstract

Intraductal papillary mucinous neoplasm (IPMN) is the most common pancreatic cystic neoplasm (PCN). The increased attention to IPMN is due to its unique features of malignant progression, being different between main duct IPMN and branch duct IPMN, and increased de novo development of conventional pancreatic ductal adenocarcinoma elsewhere in the pancreas. The increased interest in IPMN led to publication of many guidelines on its clinical management. This chapter aims to summarize and compare characteristics of nine guidelines on the clinical management of IPMN and other PCNs published in the English literature and further to show a current strategy for surgical decision making in the management of IPMN.

Entities:  

Keywords:  Intraductal papillary mucinous neoplasm; Pancreatic cancer; Pancreatic ductal adenocarcinoma

Mesh:

Year:  2019        PMID: 30378040     DOI: 10.1007/978-1-4939-8879-2_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  A retrospective study of histological outcome for IPMN after surgery in Lausanne, Switzerland: A case series.

Authors:  Alexis Litchinko; Kosuke Kobayashi; Nermin Halkic
Journal:  Ann Med Surg (Lond)       Date:  2020-10-20

2.  The Impact of Patient Age ≥80 Years on Postoperative Outcomes and Treatment Costs Following Pancreatic Surgery.

Authors:  Andreas Andreou; Pauline Aeschbacher; Daniel Candinas; Beat Gloor
Journal:  J Clin Med       Date:  2021-02-10       Impact factor: 4.241

3.  Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.

Authors:  Sijia Cui; Tianyu Tang; Qiuming Su; Yajie Wang; Zhenyu Shu; Wei Yang; Xiangyang Gong
Journal:  Cancer Imaging       Date:  2021-03-09       Impact factor: 3.909

4.  Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation.

Authors:  Xian Zhou; Zhichao Sun; Mengdi Zhang; Xiaoyu Qu; Shuhui Yang; Lianmei Wang; Yanling Jing; Li Li; Weiwei Deng; Fangming Liu; Jin Di; Jie Chen; Jian Wu; Hongbing Zhang
Journal:  Animal Model Exp Med       Date:  2022-01-22

5.  Clinical Implication of Preoperative C-Reactive Protein/Albumin Ratio in Malignant Transformation of Intraductal Papillary Mucinous Neoplasm: A Propensity Score Analysis.

Authors:  Hirotsugu Maruyama; Kojiro Tanoue; Yuki Ishikawa-Kakiya; Masafumi Yamamura; Akira Higashimori; Masaki Ominami; Yuji Nadatani; Shusei Fukunaga; Koji Otani; Shuhei Hosomi; Fumio Tanaka; Noriko Kamata; Yasuaki Nagami; Koichi Taira; Go Ohira; Kenjiro Kimura; Ryosuke Amano; Yasuhiro Fujiwara
Journal:  Diagnostics (Basel)       Date:  2022-02-21

6.  MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasm.

Authors:  Tingting Lin; Xin Chen; Jingjing Liu; Yingying Cao; Wenjing Cui; Zhongqiu Wang; Cheng Wang; Xiao Chen
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

7.  Use of Autoreactive Antibodies in Blood of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) for Grade Distinction and Detection of Malignancy.

Authors:  Niall Brindl; Henning Boekhoff; Andrea S Bauer; Matthias M Gaida; Hien T Dang; Jörg Kaiser; Jörg D Hoheisel; Klaus Felix
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

8.  Automated Detection of Pancreatic Cystic Lesions on CT Using Deep Learning.

Authors:  Lorraine Abel; Jakob Wasserthal; Thomas Weikert; Alexander W Sauter; Ivan Nesic; Marko Obradovic; Shan Yang; Sebastian Manneck; Carl Glessgen; Johanna M Ospel; Bram Stieltjes; Daniel T Boll; Björn Friebe
Journal:  Diagnostics (Basel)       Date:  2021-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.